Target intelligence / Profile preview

MicroRNA 3193 (MIR3193)

Target
MIR3193
Molecular classification
microRNA, Non-coding RNA, RNA gene
01

Overview

MicroRNA 3193 (MIR3193) is a human microRNA gene that encodes a non-coding RNA molecule, part of the microRNA family which are 20–24 nucleotide RNAs that regulate gene expression post-transcriptionally by binding to target mRNAs, leading to their translational inhibition or destabilization. MIR3193 is processed from a primary transcript by Drosha and Dicer enzymes, resulting in a mature microRNA incorporated into the RISC complex to mediate its effects. There is limited functional or disease-specific data for MIR3193: while its dysregulation has been reported in some databases, its biological and pathological roles remain largely uncharacterized and it is not currently established as a therapeutic target or biomarker. MicroRNAs are a large family of non-coding RNAs involved in gene regulation, and the MIR3193 gene codes for one such microRNA. The biogenesis and function of microRNAs is well established: they are transcribed, processed by Drosha/Dicer, and incorporated into RISC for gene regulation via mRNA targeting. There is no evidence that MIR3193 is a drug target, receptor, enzyme, transporter, or transcription factor. It is strictly a non-coding gene product. While some databases note statistical associations (e.g., with Leopard syndrome 1), this is not equivalent to the causal or mechanistic roles seen with established drug targets, nor does it place MIR3193 into cancer, cardiovascular, or neurodegenerative disease pathways as of current literature. There are no known drugs, mechanisms of action, or biomarker status for MIR3193, nor are there described safety concerns for targeting it, as it is not targeted therapeutically. This entry differs from well-characterized microRNAs like miR-193a-3p (which has reported tumor suppressor roles and more established disease biology). There is no indication of misspelling or fundamental error for this target, but it is not an established or actionable therapeutic target according to the current major databases or literature.

Other names
hsa-mir-3193miR-3193MIR3193
02

Biological functions

Post-transcriptional regulation of gene expressionmRNA stability modulationTranslation inhibition
03

Disease associations

Other (Reported association: Leopard syndrome 1; no strong evidence of causality or function in major disease classes based on current data)

Beyond the preview

Go deeper on MicroRNA 3193 (MIR3193).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3193 (MIR3193).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call